Ocular Therapeutix, Inc.OCUL stock score: 38/100
$5.86 · -1.35% · Scored Nov 19, 2026
- Technical
- 24
- Fundamental
- 42
- News
- —
The reading
Ocular Therapeutix (OCUL) scores 38 out of 100, which reads bearish, higher than 18% of Healthcare stocks and 19% of the 4,118 US stocks we score.
The composite weights fundamentals 80% and technicals 20%: fundamentals read 42, technicals 24.
Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 15 and contrarian oscillators 66 — a split worth reading before trusting the technical total.
Since Aug 22, 2026 the composite has ranged from 31 to 51, and it is down 12 points over the period.
About Ocular Therapeutix
Ocular Therapeutix (OCUL) is a biopharmaceutical company based in Bedford, Massachusetts, that develops eye treatments using a bioresorbable hydrogel that releases drugs slowly over time. Its lead candidate, AXPAXLI, is an implant injected into the eye that releases axitinib, a drug that blocks blood vessel growth, and it is designed to treat wet age-related macular degeneration with far fewer injections than current therapies. AXPAXLI met its main goal in a late-stage trial against aflibercept, a widely used treatment, and a second late-stage trial is under way, with the company pursuing U.S. approval. Ocular already sells DEXTENZA, a dexamethasone insert placed in the tear duct to treat inflammation and pain after eye surgery and itching from allergic conjunctivitis, which provides its current product revenue.
In wet AMD, Ocular competes with Regeneron’s Eylea, Roche’s Vabysmo and Susvimo, and Novartis, as well as with EyePoint Pharmaceuticals, which is developing another long-acting implant. Its edge rests on an implant that may extend time between treatments to many months and on hydrogel technology already used in an approved product. Investors who follow OCUL stock tend to watch data from the second AXPAXLI late-stage trial and progress toward a marketing application. Safety findings and the regulatory path are closely followed. DEXTENZA sales, cash runway and commercial preparations are other factors.
What’s driving the score
The strongest and weakest of the scorers that count toward OCUL’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
42Pulling it up
- Quick Ratio100
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
Current assets divided by current liabilities: the ability to pay short-term bills.
Holding it back
Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.
How reliably yearly earnings grow: the share of years with higher earnings, the compound growth rate, how steady that growth is, and the last two yearly changes.
Absolute profitability: whether the company is profitable, its net margin against the sector range, and how consistently it has been profitable over three years.
38 weighted scorers; 1 had no data today and are left out rather than counted as zero.
Technical · daily
20Pulling it up
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
Money Flow Index (14-period) is a volume-weighted RSI that identifies overbought and oversold conditions.
- RSI (14)80
Relative Strength Index (14-period) measures momentum by comparing recent gains to losses.
Holding it back
S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.
Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.
Where the price sits between its 52-week low and high.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 38 | 1 |
| Daily | 20 | 3 |
| Weekly | 18 | 2 |
| Monthly | 29 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Nov 19, 2026 | 38 |
| Nov 18, 2026 | 38 |
| Nov 17, 2026 | 38 |
| Nov 16, 2026 | 38 |
| Nov 15, 2026 | 38 |
| Nov 14, 2026 | 38 |
| Nov 13, 2026 | 38 |
| Nov 12, 2026 | 36 |
| Nov 11, 2026 | 33 |
| Nov 10, 2026 | 32 |
| Nov 8, 2026 | 32 |
| Nov 7, 2026 | 32 |
| Nov 6, 2026 | 32 |
| Nov 5, 2026 | 32 |
| Nov 4, 2026 | 36 |
| Nov 3, 2026 | 33 |
| Nov 2, 2026 | 32 |
| Nov 1, 2026 | 35 |
| Oct 30, 2026 | 34 |
| Oct 29, 2026 | 36 |
| Oct 28, 2026 | 35 |
| Oct 27, 2026 | 34 |
| Oct 26, 2026 | 32 |
| Oct 25, 2026 | 32 |
| Oct 24, 2026 | 31 |
| Oct 23, 2026 | 32 |
| Oct 22, 2026 | 32 |
| Oct 21, 2026 | 32 |
| Oct 20, 2026 | 32 |
| Oct 19, 2026 | 31 |
| Oct 18, 2026 | 32 |
| Oct 17, 2026 | 32 |
| Oct 16, 2026 | 32 |
| Oct 15, 2026 | 33 |
| Oct 14, 2026 | 34 |
| Oct 13, 2026 | 34 |
| Oct 12, 2026 | 35 |
| Oct 11, 2026 | 35 |
| Oct 10, 2026 | 35 |
| Oct 9, 2026 | 35 |
| Oct 8, 2026 | 34 |
| Oct 7, 2026 | 33 |
| Oct 6, 2026 | 34 |
| Oct 5, 2026 | 33 |
| Oct 4, 2026 | 32 |
| Oct 3, 2026 | 32 |
| Oct 2, 2026 | 32 |
| Oct 1, 2026 | 32 |
| Sep 30, 2026 | 34 |
| Sep 29, 2026 | 35 |
| Sep 28, 2026 | 35 |
| Sep 27, 2026 | 42 |
| Sep 26, 2026 | 42 |
| Sep 25, 2026 | 42 |
| Sep 24, 2026 | 46 |
| Sep 23, 2026 | 48 |
| Sep 22, 2026 | 49 |
| Sep 21, 2026 | 45 |
| Sep 20, 2026 | 46 |
| Sep 19, 2026 | 46 |
| Sep 18, 2026 | 45 |
| Sep 17, 2026 | 47 |
| Sep 16, 2026 | 44 |
| Sep 15, 2026 | 46 |
| Sep 14, 2026 | 48 |
| Sep 13, 2026 | 48 |
| Sep 12, 2026 | 48 |
| Sep 11, 2026 | 47 |
| Sep 10, 2026 | 49 |
| Sep 9, 2026 | 51 |
| Sep 8, 2026 | 51 |
| Sep 7, 2026 | 49 |
| Sep 6, 2026 | 49 |
| Sep 5, 2026 | 49 |
| Sep 4, 2026 | 48 |
| Sep 3, 2026 | 50 |
| Sep 2, 2026 | 50 |
| Sep 1, 2026 | 49 |
| Aug 31, 2026 | 48 |
| Aug 30, 2026 | 48 |
| Aug 29, 2026 | 47 |
| Aug 28, 2026 | 48 |
| Aug 27, 2026 | 49 |
| Aug 26, 2026 | 50 |
| Aug 25, 2026 | 49 |
| Aug 24, 2026 | 49 |
| Aug 23, 2026 | 50 |
| Aug 22, 2026 | 50 |
Key facts
- Market cap
- $1.3B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 1.22
- Risk grade (1–10)
- 9
- Next earnings
- Feb 4, 2027
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| INVA Innoviva | $1.3B | 63 |
| LBRX LB Pharmaceuticals | $1.3B | 41 |
| GHRS GH Research | $1.3B | 42 |
| NVAX Novavax | $1.3B | 55 |
| MNKD MannKind | $1.3B | 56 |
| MLYS Mineralys Therapeutics | $1.3B | 31 |
Questions
What is OCUL's stock rating today?
OCUL scores 38/100 (Bearish) as of Nov 19, 2026: technical 24, fundamental 42. Scores are recomputed every night.
What does Ocular Therapeutix do?
Ocular Therapeutix (OCUL) is a biopharmaceutical company based in Bedford, Massachusetts, that develops eye treatments using a bioresorbable hydrogel that releases drugs slowly over time. Its lead candidate, AXPAXLI, is an implant injected into the eye that releases axitinib, a drug that blocks blood vessel growth, and it is designed to treat wet age-related macular degeneration with far fewer injections than current therapies.
Is OCUL stock a buy?
The score is not a buy or sell recommendation. A 38 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the OCUL score calculated?
100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.
Embed this score
A badge for a blog post, newsletter or README. It updates every night and links back here. More badges
HTML
<a href="https://stocksscores.com/stocks/ocul/"><img src="https://stocksscores.com/stocks/ocul/badge.svg" alt="OCUL stock score" height="20"></a>
Markdown
[](https://stocksscores.com/stocks/ocul/)